Voya Investment Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Voya Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $38,486 - $47,458	-2,183 Reduced 17.11%	10,575 $208,000
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $5,345 - $7,094	-372 Reduced 2.83%	12,758 $223,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $3,017 - $4,762	289 Added 2.25%	13,130 $184,000
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $92,020 - $135,794	-8,600 Reduced 40.11%	12,841 $138,000
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $29,794 - $44,483	-2,609 Reduced 10.85%	21,441 $321,000
Q3 2022 Mar 03, 2023	BUY	$9.76 - $13.41 $25,463 - $34,986	2,609 Added 12.17%	24,050 $308,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $118,310 - $162,556	12,122 Added 101.63%	24,050 $309,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $1,039 - $1,515	100 Added 0.85%	11,928 $140,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $1,797 - $2,596	-136 Reduced 1.14%	11,828 $165,000
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $9,691 - $13,926	581 Added 5.1%	11,964 $221,000
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $168,468 - $240,750	11,383 New	11,383 $201,000

1.89M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $862M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.